Shares of Catalyst Pharmaceuticals fell 5.6% to $4.04 at 11:14 EST on Tuesday, following last session’s upward trend. NASDAQ Composite is sliding 1.72% to $13,300.74, following last session’s downward trend, This seems, up to now, an all-around rough trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $4.37, 30.69% below its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the current quarter and 5.5% for the next. The company’s growth estimates for the present quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was 3.31%, 6.05%, and 2.62%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 4.76%, 7.95%, and 5.00%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $4.04 at 11:14 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is above its 50-day moving average of $3.83 and way higher than its 200-day moving average of $3.49.

LEAVE A REPLY

Please enter your comment!
Please enter your name here